JPRN-UMIN000013038
Completed
未知
Analysis of pharmacokinetics and pharmacodynamics for capecitabine during new chemotherapy regimen by bevacizumab (Bev) in combination with XELOX in unresectable colorectal cancer - Analysis of pharmacokinetics and pharmacodynamics for Capecitabine during new chemotherapy regimen
Tsukasa Hotta0 sites10 target enrollmentFebruary 1, 2014
Conditionsunresectable colorectal cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- unresectable colorectal cancer
- Sponsor
- Tsukasa Hotta
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Treatment for ascites and thoracic effusion is needed. 2\.There is brain tumor or brain metastasis. 3\.Untreated double cancer within 5 years 4\.There is cerebrovascular disease 5\.surgery within 4 weeks 6\.surgery for study 7\.use of drug effected for blood coagulation system 8\.Bleeding tendency 9\.Uncontrorable peptic ulcer 10\.gastrointestinal perforation within 6 months 11\.untreated fructure 12\.renal failure 13\.Uncontrorable hypertension 14\.Uncontrorable diabetes meritus 15\.heart disease 16\.hypersensitivity for fluorouracil and platinum 17\.DPD defect 18\.Uncontrorable diarrhea 19\.interstitial pneumonia or pulmonary fibrosis 20\.organ transplant needed immunosuppressant drug 21\.Uncontrorable infectious disease 22\.similarterm for BV treatment 23\.difficult for oral intake
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A study on the pharmacokinetics and pharmacodynamics of remimazolam during total intravenous anesthesia with remifentanilNot ApplicableKCT0007066Inje University Busan Paik Hospital15
Active, not recruiting
Phase 1
study of the pharmacokinetics and pharmacodynamics of desmopressin oral lyophilisate - route of administration in the pediatric patient population - SAFEPEDRUGEUCTR2014-005200-13-BEGhent University24
Recruiting
Not Applicable
Pharmacokinetic, pharmacodynamic and pharmacogenetic research on biomarkers in cancer patients with special response to pharmacological therapyMalignancyJPRN-UMIN000011798Medical Oncology / Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine600
Completed
Not Applicable
Assessment of pharmacokinetics and pharmacokinetic drug-drug interaction with ketoconazole of the metabolite S 41015 after single oral unlabelled microdoses of S 41015 and i.v. radiolabelled microdoses of [14C]-S 41015, and pharmacokinetics of S 38844 after single oral unlabelled microdose of S 38844 and i.v. radiolabelled microdose of [14C]-S 38844 in healthy male participantshart- en vaatziektencardiovascular diseasesNL-OMON38625Institut de Recherches Internationales Servier I.R.I.S6
Active, not recruiting
Not Applicable
A Study of the Pharmacodynamics, Pharmacokinetics, and Safety & Efficacy of ARC1779 Injection in Patients with von Willebrand Disease Type 2B - ARC1779 for VWD-2Bvon Willebrand Disease type 2BEUCTR2008-008532-82-ATMedical University of Vienna, Dept. of Clinical Pharmacology